Statins for infection and sepsis: a systematic review of the clinical evidence.
Abstract
INTRODUCTION: Statins are currently used for hyperlipidaemia control and considered useful for protection from cardiovascular events. In addition, there is increasing evidence for the potential use of statins in preventing and treating infections. METHODS: We performed a systematic review of the literature that compared the outcome between statin and non-statin users among patients suffering from sepsis or other infections. The relevant studies were identified from searches of PubMed, Scopus and the Cochrane Library databases. RESULTS: Twenty studies were identified (13 of them were retrospective), out of which 9 examined the use of statins in patients with sepsis, bacteraemia or multiorgan dysfunction syndrome, 4 community-acquired pneumonia (CAP), 1 ICU infections, 2 other bacterial infections and 4 viral infections. Eleven studies had data regarding mortality as the main outcome: 8 showed decreased mortality in statin users (3 of them reported on patients with bacteraemia), 2 showed no difference in mortality and 1 reported an increased mortality in patients who received statins. Seven studies examined the risk of sepsis as the main outcome; six of these studies showed a decreased risk of sepsis in patients receiving statins, whereas one study found no difference. CONCLUSIONS: The majority of the studies suggest that statins may have a positive role in the treatment of patients with sepsis and infection. However, the majority of the reviewed studies have the inherent methodological limitations of retrospective studies. Conclusions regarding this important clinical question should wait for the results of ongoing relevant randomized controlled trials.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Meta-analyses and systematic reviews on statins and infection have yielded inconclusive results.
“Moreover, a considerable number of meta-analyses and systematic reviews have examined the literature on statins and infection with rather inconclusive results (Falagas et al., 2008; Gao et al., 2008; Kopterides and Falagas, 2009; Tleyjeh et al., 2009, 2012; Bjorkhem-Bergman et al., 2010; Janda et al., 2010; van den Hoek et al., 2011; Ma et al., 2012; Wan et al., 2014; Wang et al., 2014).”
From Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice (2015) · cites this paper as Falagas et al., 2008
Cites
Slim, K., Nini, E., Forestier, D., Kwiatkowski, F., Panis, Y., & Chipponi, J. (2003) · ANZ Journal of Surgery · doi:10.1046/j.1445-2197.2003.02748.x · Cited by 7,603 · see citing works
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · see citing works
The Natural History of the Systemic Inflammatory Response Syndrome (SIRS)
Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., & Wenzel, R. P. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,090 · see citing works
Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M. D., Zeller, L., & Danon, A. (2004) · Circulation · doi:10.1161/01.cir.0000138932.17956.f1 · Cited by 399 · see citing works
Brookhart, M. A., Patrick, A. R., Dormuth, C. R., Avorn, J., Shrank, W. H., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 386 · see citing works
The Effect of Statins on Mortality in Patients with Bacteremia
Liappis, A. P., Kan, V. L., Rochester, C. G., & Simon, G. L. (2001) · Clinical Infectious Diseases · doi:10.1086/323334 · Cited by 335 · see citing works
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
Hackam, D. G., Mamdani, M., Li, P., & Redelmeier, D. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68041-0 · Cited by 317 · see citing works
Influenza and COPD Mortality Protection as Pleiotropic, Dose-Dependent Effects of Statins
Frost, F. J., Petersen, H. V., Tollestrup, K., & SKIPPER, B. J. (2007) · CHEST Journal · doi:10.1378/chest.06-1997 · Cited by 301 · see citing works
Majumdar, S. R., McAlister, F. A., Eurich, D. T., Padwal, R. S., & Marrie, T. J. (2006) · BMJ · doi:10.1136/bmj.38992.565972.7c · Cited by 270 · see citing works
Statins and sepsis: multiple modifications at multiple levels
Terblanche, M., Almog, Y., Rosenson, R. S., Smith, T. S., & Hackam, D. G. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70111-1 · Cited by 269 · see citing works
Statin therapy is associated with fewer deaths in patients with bacteraemia
Krüger, P., Fitzsimmons, K., Cook, D., Jones, M., & Nimmo, G. R. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2859-y · Cited by 234 · see citing works
Rundek, T., Naini, A., Sacco, R. L., Coates, K., & DiMauro, S. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.889 · Cited by 229 · see citing works
Mortensen, E. M., Restrepo, M. I., Anzueto, A., & Pugh, J. A. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-82 · Cited by 189 · see citing works
Bonovas, S., Filioussi, K., Tsavaris, N., & Sitaras, N. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3560 · Cited by 171 · see citing works
Statin use and mortality within 180 days after bacteremia: A population-based cohort study*
Thomsen, R. W., Hundborg, H. H., Johnsen, S. P., Pedersen, L. H., Sørensen, H. T., Schønheyder, H. C., & Lervang, H.-H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000207345.92928.e4 · Cited by 160 · see citing works
Statins and the Risk of Pneumonia: A Population‐Based, Nested Case‐Control Study
Schlienger, R. G., Fedson, D. S., Jick, S. S., Jick, H., & Meier, C. R. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.325 · Cited by 147 · see citing works
Statin treatment and reduced risk of pneumonia in patients with diabetes
van de Garde, E. M. W., Hak, E., Souverein, P. C., Hoes, A. W., van den Bosch, J. M. M., & Leufkens, H. G. M. (2006) · Thorax · doi:10.1136/thx.2006.062885 · Cited by 132 · see citing works
Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
Gupta, R., Plantinga, L., Fink, N. E., Melamed, M. L., Coresh, J., Fox, C. S., Levin, N. W., & Powe, N. R. (2007) · JAMA · doi:10.1001/jama.297.13.1455 · Cited by 121 · see citing works
Schmidt, H., Hennen, R., Keller, A., Ruß, M., Müller‐Werdan, U., Werdan, K., & Buerke, M. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0246-y · Cited by 103 · see citing works
Almog, Y., Novack, V., Eisinger, M., Porath, A., Novack, L., & Gilutz, H. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000253397.42079.d5 · Cited by 102 · see citing works
Statin therapy prior to ICU admission: protection against infection or a severity marker?
Fernández, R., de Pedro, V. J., & Artigas, A. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2743-9 · Cited by 94 · see citing works
Effectiveness of Statins in Reducing the Rate of Severe Sepsis: A Retrospective Evaluation
Martin, C. P., Talbert, R. L., Burgess, D. S., & Peters, J. I. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.20 · Cited by 72 · see citing works
Evaluation of the anti-HIV activity of statins
Moncunill, G., Negredo, E., Bosch, L., et al. (2005) · AIDS · doi:10.1097/01.aids.0000183517.60384.db · Cited by 58 · see citing works
Horne, B. D., Muhlestein, J. B., Carlquist, J. F., Bair, T. L., Madsen, T. E., Hart, N. I., & Anderson, J. L. (2003) · Circulation · doi:10.1161/01.cir.0000045668.71683.92 · Cited by 51 · see citing works
Col, N. F., & Pauker, S. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00011 · Cited by 51 · see citing works
Sklar, P. A., Masur, H., Grubb, J. R., Voell, J., Witek, J., Ono, A., Freed, E. O., & Maldarelli, F. M. (2005) · AIDS · doi:10.1097/01.aids.0000174461.31794.50 · Cited by 32 · see citing works
Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy
Hauer‐Jensen, M., Fort, C., Mehta, J. L., & Fink, L. M. (2005) · Hernia · doi:10.1007/s10029-005-0030-x · Cited by 24 · see citing works
Some Surprises, Some Answers, and More Questions About Hormone Therapy
Petitti, D. B. (2005) · JAMA · doi:10.1001/jama.294.2.245 · Cited by 6 · see citing works
The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy
Col, N. F., & Pauker, S. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00027 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554 · see citing works
Reduction in Mortality Associated with Statin Therapy in Patients with Severe Sepsis
Dobesh, P. P., Klepser, D. G., McGuire, T. R., Morgan, C. W., & Olsen, K. M. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.621 · Cited by 88 · see citing works
Nyilasi, I., Kocsubé, S., Krizsán, K., Galgóczy, L., Pesti, M., Papp, T., & Vágvölgyi, C. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01972.x · Cited by 83 · see citing works
Sun, H., & Singh, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597039 · Cited by 65 · see citing works
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice
Rahal, E. A., Constantin, W. N., Zeidan, N., & Abdelnoor, A. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01474 · Cited by 14 · see citing works
- Authors
- Falagas, M. E., Makris, G. C., Matthaiou, D. K., & Rafailidis, P. I.
- Affiliations
- Tufts University (US)
- Alfa Institute of Biomedical Sciences (GR)
- Corresponding author
- Falagas, M. E.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02-04
- Volume
- 61
- Issue
- 4
- Pages
- 774-785
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2126287031
- Cited by
- 166
- References
- 30
- Citations by year
- 2025: 6 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 8 · 2015: 11 · 2014: 16 · 2013: 10 · 2012: 15
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- statins, sepsis, infection, community-acquired pneumonia, bacteremia, multiple organ failure, viral infection, bacterial infection, mortality, sepsis risk, immunomodulation
- MeSH terms
- Anti-Infective Agents, Bacterial Infections, Humans, Virus Diseases, Sepsis, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review